The present invention is based on the surprising and unexpected finding that the ratio of the C/C genotype of -509 C/T TGF-β1 polymorphisms is higher among patients with post-traumatic tracheal scar tissue. Therefore, the determination of this polymorphism offers a good possibility to forecast susceptibility to the development of post-traumatic tracheal scar tissue.

The new DNA kit is able to use in that cases where post traumatic scar tissue can evolve. Especially intubated patients.

Benefits of the invention:

—     early stage diagnostic of post-traumatic tracheal scar tissue

—     patient-friendly method

—     opportunity for prophylaxis

—     easy and simple way to diagnose accurately

economical to use

View a detailed description in the R&D Repository »

Request a proposal

Valorisation Plan Authors

Related Documents

There in no related documents

Visit the other applications of the INTERVALUE Platform: R&D Repository | IP Agreements

© 2009-2010 INTERVALUE Project